Sign up for the FDAzilla monthly newsletter which is packed with new data insights, 483/inspection trends, and more!

First Name *

Last Name *

Email *

Company *

Job Title *

Also send me more information on FDAzilla's subscription services

Log In
Store

Tag Archives: regulatory affairs

Top 5 FDA 483/Warning Letter/Inspection Stories of 2013

It has been quite a year for FDA 483s and Warning Letters. Here are the top 5 stories for 2013: Continue reading →

This entry was posted in CGMP, cGMP Quality Assurance and FDA 483s, Devices, Drugs, FDA, FDA Inspections, Form FDA 483, News, quality assurance and tagged regulatory affairs on December 23, 2013 by Tony Chen.

SUBSCRIBE TO OUR MONTHLY NEWSLETTER >>

Search this blog

Search for:

Browse Blog by Topic

Browse Blog by Topic

RECENT Posts

CHINA DRUG INSPECTIONS, 2016 July 21, 2017
STARTING MATERIALS SELECTION and JUSTIFICATION July 21, 2017
FDA Sent These 5 Warning Letters for Pharma Companies | June 2017 July 12, 2017
FDA issued 47 Product Recalls, Import Alerts, and Consent Decrees in May 2017 June 21, 2017
FDA Sent These 6 Warning Letters for Pharma Companies | May 2017 June 14, 2017

Top Posts

CHINA DRUG INSPECTIONS, 2016
Warning Letters 2016 - Data Governance & Data Integrity
FDA and MHRA MOST RECENT INSPECTION OBSERVATIONS
28 Unique Data Integrity Deficiencies That Aren't Really Unique
How the FDA has changed, How the 483 has changed, & How we should use 483s to get smarter

FAVORITE POSTS

Infographic: 15 years of FDA Inspection Data
Does an FDA Import Alert automatically equate to an impending FDA Warning Letter?
FDA Investigators are Inspecting a Record Number of Asian Pharmaceutical Sites
Data Integrity: The Whole Story
4 Trends About GMP Inspection Readiness and FDA Data Intelligence
FDA Getting Tougher
7 Resources to Avoid FDA 483s
31 Websites on the FDA
Funny FDA story from Costa Rica

How can we help you?

Enforcement Analytics
FDA 483 Download Service
GMP Regulatory Intelligence
FDA 483 & EIR Store

Copyright (r) 2010-2017 - FDAzilla.com and Govzilla, Inc., All rights reserved. Unauthorized publication is strictly prohibited.

About
Services
Inspectors
Privacy
Terms

©2017 FDAzilla

Receive the industry's most relevant updates and expert opinions.

Subscribe to FDAzilla's Monthly Newsletter

Yes, please sign me up to receive the industry’s most relevant updates and expert opinions.